...BRCA2 testing for hereditary breast and ovarian cancer is one such widely used test. However, clinical testing methods w...
...BRCA2. Most BRCA2 germline mutations introduce premature termination codons (PTCs), making their mRNAs likely targets of...
To estimate the likelihood of occult cancer diagnosis at prophylactic oophorectomy in BRCA1 and BRCA2 carriers in differ...
...BRCA2 mutation carriers who face very high lifetime risks of both breast and ovarian cancers.,We conducted a matched cas...
...BRCA2 germ line mutation carriers, 72 members of hereditary breast and ovarian cancer (HBOC) families and 88 breast canc...
...BRCA2). FA-A is the most common complementation group, accounting for approximately 65% of all affected individuals. The...
...BRCA2 mutation, and overexpression of ki-67, 14-3-3sigma, and mesothelin. Ductal neoplasia is the most important categor...
...BRCA2. Cells treated with E2 or 4-OHE2 at doses of 0.007 and 70 nM and 2-OHE2 only at a higher dose (3.6 microM) showed ...
...Brca2 allele has not taken place. In this study, we have treated Brca2-deficient small intestine with a potent small-mol...
...BRCA2 are also discussed.
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
